Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or ...
A pharmacist holds a Pfizer and BioNTech COVID-19 vaccine shot on Thursday, April 24, 2025, in Portland, Ore. University of Florida researchers found that advanced lung and skin cancer patients lived ...
But a new study suggests one more factor deserves serious attention—chronological age. Researchers from University Hospitals ...
Everyday Health on MSN
Expert Q&A: Your Questions About the Cost of ADT for Advanced Prostate Cancer, Answered
Dr. Adam Weiner answers common questions about the costs of androgen deprivation therapy (ADT) for advanced prostate cancer and how to find help paying for it.
Columbus Ledger-Enquirer on MSN
Trump, RFK Jr. Respond Over Cancer Treatment Battle
Cartoonist Scott Adams has appealed directly to President Donald Trump for assistance in securing immediate administration of ...
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...
News-Medical.Net on MSN
Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...
Find out how ADT + ARPI outperforms ADT alone in mHSPC, boosting survival and treatment persistence. Read more on real-world outcomes.
BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...
An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib (Talzenna) plus enzalutamide (Xtandi) for all patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback